(E)-ETHYL 3-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACRYLATE, 95%, 1g

Anti-6xHis Monoclonal Antibody (6A12) HRP Conjugate1vial

Benzoyleneurea, 99.00%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhex-4-enoic acid, 98+%, 100mg

7-Iodo-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 100mg

4-Hydroxycyclohexanone monoethylene ketal, 98.0%, 5g

(R)-6-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-2-methylheptan-2-ol, 98%, 50mg

4,6-Dimethyl-2-mercaptopyrimidine, 98% (contains <15%H2O), 98.0%, 100g

6-Chloro-1H-pyrazolo[3,4-d]pyrimidine, 95.0%, 1g

2,3-Difluoro-6-nitrotoluene, 95.0%, 25g

5-Ethoxypicolinic acid, 95.0%, 10g

3-Oxo-2,3-dihydropyridazine-4-carboxylic acid, 95.0%, 500mg

Boc-L-Pyroglutamic acid methyl ester, 97.0%, 25g